Clinical Trial Update: Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing aflibercept versus ranibizumab for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Minia University | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED